Annual Drug Patent Expirations for MYTESI
Mytesi is a drug marketed by Napo Pharms Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has forty-one patent family members in twenty-five countries.
The generic ingredient in MYTESI is crofelemer. One supplier is listed for this compound. Additional details are available on the crofelemer profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com